Gilead (GILD), Amgen (AMGN) and Vertex Pharmaceuticals (VRTX) are some of the most trending stocks in the biotech sector. See how they compare to other companies such as Biogen (BIIB), Illumina (ILMN) and Regeneron (REGN).

Compare up to 10 stocks

Clear

GILD AMGN VRTX BIIB ILMN REGN MRNA IQV MTD BNTX

Comparison Results

Name	Price	Price Change	Analyst Price Target	Market Cap	Yearly Gain	Analyst Consensus	Smart Score
GILD Gilead Sciences	$85.61	▲ $0.4 (0.47%)	$82.19 (-3.99% Downside)	$106.87B	28.59%	9 Buy 8 Hold 0 Sell Moderate Buy	premium
AMGN Amgen	$281.78	▼ $0.84 (0.3%)	$259.57 (-7.88% Downside)	$150.80B	45.56%	4 Buy 7 Hold 4 Sell Hold	premium
VRTX Vertex Pharmaceuticals	$315.38	▲ $0.08 (0.03%)	$325.41 (3.18% Upside)	$80.93B	70.48%	12 Buy 7 Hold 0 Sell Moderate Buy	premium
BIIB Biogen	$291.46	▼ $0.44 (0.15%)	$308.83 (5.96% Upside)	$42.03B	29.24%	19 Buy 7 Hold 0 Sell Moderate Buy	premium
ILMN Illumina	$210.09	▼ $6.82 (3.14%)	$248.46 (18.26% Upside)	$34.12B	-40.78%	7 Buy 5 Hold 2 Sell Moderate Buy	premium
REGN Regeneron	$730.00	▼ $11.48 (1.55%)	$813.00 (11.37% Upside)	$80.74B	14.44%	12 Buy 8 Hold 1 Sell Moderate Buy	premium
MRNA Moderna	$174.59	▼ $0.79 (0.45%)	$200.38 (14.77% Upside)	$67.38B	-52.13%	8 Buy 6 Hold 0 Sell Moderate Buy	premium
IQV IQVIA Holdings	$213.51	▼ $0.94 (0.44%)	$254.73 (19.31% Upside)	$39.83B	-16.06%	10 Buy 1 Hold 0 Sell Strong Buy	premium
MTD Mettler-Toledo	$1428.73	▼ $11.16 (0.78%)	$1,304.75 (-8.68% Downside)	$32.10B	-3.14%	1 Buy 2 Hold 1 Sell Hold	premium
BNTX BioNTech SE	$163.78	▲ $2.29 (1.42%)	$203.88 (24.48% Upside)	$39.25B	-55.07%	3 Buy 5 Hold 0 Sell Moderate Buy	premium

Performance Comparison

Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.

Biotech Stocks Latest News

Early notable gainers among liquid option names on November 28th

Notable gainers among liquid option names this morning include Moderna (MRNA) $182.35 +5.95, PayPal (PYPL) $81.93 +1.85, Vertex...

1d ago

TGT

AMZN

Gilead, Arcus provide update from fourth interim analysis of ARC-7 study

Gilead (GILD) and Arcus Biosciences (RCUS) announced an update from the fourth interim analysis of the randomized, open-label...

1d ago

GILD

RCUS

Second death linked to Eisai’s lecanemab Alzheimer’s drug, Science says

A 65-year-old woman who was receiving Eisai’s (ESALY) lecanemab treatment to slow the cognitive decline caused by her...

1d ago

BIIB

Barclays reiterates $210 target on Moderna after PSV deep dive

Barclays analyst Gena Wang reiterates an Overweight rating on Moderna with a $210 price target after conducting a...

1d ago

MRNA

Mettler-Toledo International Inc. Announces Change to Board of Directors

Columbus, OH, Nov. 23, 2022 (GLOBE NEWSWIRE) — Mettler-Toledo International Inc. (NYSE:MTD) announced today that Olivier...

6d ago

MTD

Hedge Fund Point 72 Builds Position in These Stocks; Should You?

Billionaire investor and hedge fund manager Steve Cohen’s Point 72 Asset Management has disclosed some interesting stakes in...

14d ago

BIIB

DELL

Moderna says bivalent booster shows superiority against omicron variants

Earlier, Moderna announced that both of Moderna’s bivalent Omicron-targeting booster candidates – mRNA-1273.214 and mRNA-1273.222 – trigger a...

15d ago

MRNA

Illumina participates in a conference call with JPMorgan

Life Science Tools Analyst Qin holds a conference call with CEO deSouza on November 14 at 12 pm...

15d ago

ILMN

Early notable gainers among liquid option names on November 14th

Notable gainers among liquid option names this morning include Moderna (MRNA) $179.33 +8.13, Biogen (BIIB) $301.80 +12.35, McKesson...

15d ago

MCK

MRK

Piper still cautious on Biogen but says Roche failure a positive

Piper Sandler analyst Christopher Raymond says Biogen’s (BIIB) lecanemab’s competitive position has improved with this morning’s news that...

15d ago

BIIB

Read the latest stock news and analysis from the TipRanks news team.

See All News >

Recent Analysts Ratings of Biotech Stocks

MRNA

Moderna

premium

Buy

premium

Reiterated

2022-11-28

BIIB

Biogen Inc.

premium

Buy

premium

Reiterated

2022-11-28

REGN

Regeneron Pharmaceuticals

premium

Hold

premium

Reiterated

2022-11-22

BNTX

Biontech Se Sponsored Adr

premium

Hold

premium

Reiterated

2022-11-21

IQV

IQVIA Holdings

premium

Buy

premium

Reiterated

2022-11-21

VRTX

Vertex Pharmaceuticals Inc.

premium

Buy

premium

Reiterated

2022-11-18

AMGN

Amgen Inc

premium

Sell

premium

Initiated

2022-11-17

GILD

Gilead Sciences

premium

Buy

premium

Reiterated

2022-11-15

ILMN

Illumina

premium

Buy

premium

Reiterated

2022-11-14

MTD

Mettler-toledo International

premium

Hold

premium

Upgraded

2022-11-08

All Ratings >

Most Recent Earnings of Biotech Stocks

GILD

Gilead Sciences

Oct 27, 2022

2022 (Q3)

1.43 / 1.90

2.65

-28.30% (-0.75)

AMGN

Amgen

Nov 03, 2022

2022 (Q3)

4.47 / 4.70

4.67

0.64% (+0.03)

VRTX

Vertex Pharmaceuticals

Oct 27, 2022

2022 (Q3)

3.61 / 4.01

3.56

12.64% (+0.45)

BIIB

Biogen

Oct 25, 2022

2022 (Q3)

4.13 / 4.77

4.77

0.00% (0.00)

ILMN

Illumina

Nov 03, 2022

2022 (Q3)

0.29 / 0.34

1.45

-76.55% (-1.11)

REGN

Regeneron

Nov 03, 2022

2022 (Q3)

9.76 / 11.14

15.37

-27.52% (-4.23)

MRNA

Moderna

Nov 03, 2022

2022 (Q3)

3.30 / 2.53

7.7

-67.14% (-5.17)

IQV

IQVIA Holdings

Oct 26, 2022

2022 (Q3)

2.39 / 2.48

2.17

14.29% (+0.31)

MTD

Mettler-Toledo

Nov 03, 2022

2022 (Q3)

9.84 / 10.18

8.72

16.74% (+1.46)

BNTX

BioNTech SE

Nov 07, 2022

2022 (Q3)

3.56 / 7.27

12.862

-43.48% (-5.59)

Biotech Stocks - FAQ

Which Biotech stocks have a "Strong Buy" analyst rating?

These Biotech stocks currently have a "Strong Buy" analyst rating consensus:

IQVIA Holdings - Strong Buy, based on 11 analyst ratings, 10 Buy, 1 Hold, and 0 Sell.

Are Biotech stocks overpriced?

Gilead Sciences's stock price is currently $85.61, and its average 12-month price target is $82.19.

Amgen's stock price is currently $281.78, and its average 12-month price target is $259.57.

Vertex Pharmaceuticals's stock price is currently $315.38, and its average 12-month price target is $325.41.

Biogen's stock price is currently $291.46, and its average 12-month price target is $308.83.

Illumina's stock price is currently $210.09, and its average 12-month price target is $248.46.

Regeneron's stock price is currently $730.00, and its average 12-month price target is $813.00.

Moderna's stock price is currently $174.59, and its average 12-month price target is $200.38.

IQVIA Holdings's stock price is currently $213.51, and its average 12-month price target is $254.73.

Mettler-Toledo's stock price is currently $1,428.73, and its average 12-month price target is $1,304.75.

BioNTech SE's stock price is currently $163.78, and its average 12-month price target is $203.88.

Which Biotech stocks pay dividends?

Gilead Sciences currently pays a dividend of $0.73 which represents an annual dividend yield of 3.39%. Gilead Sciences's next Ex-dividend date is December 14, 2022 and its next payout date is December 29, 2022.

Amgen does not currently pay dividends.

Vertex Pharmaceuticals does not currently pay dividends.

Biogen does not currently pay dividends.

Illumina does not currently pay dividends.

Regeneron does not currently pay dividends.

Moderna does not currently pay dividends.

IQVIA Holdings does not currently pay dividends.

Mettler-Toledo does not currently pay dividends.

BioNTech SE does not currently pay dividends.